...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.
【24h】

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

机译：关于重度抑郁症治疗安全性监测指南的共识性声明。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring. METHOD: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content. RESULTS: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment. CONCLUSION: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.
机译：目的：本文旨在概述治疗抑郁症的筛查和安全注意事项，并提出安全监测的建议。方法：数据是通过使用MEDLINE进行文献检索和对科学期刊进行人工搜索以识别相关文章而获得的。准备了准则草案，并以迭代的方式进行了系列修订，直到所有合著者最终批准了内容。结果：筛查和监测可以发现抑郁症的医学原因。与抗抑郁药治疗相关的特定不良反应可以通过在开始治疗后通过基线筛查和药物特异性监测来减少或确定。结论：在治疗临床抑郁症时采用安全监测指南可能会改善整体身体健康状况和治疗结果。在临床抑郁症的常规治疗中实施这些指南很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号